ArticleEvidence-based complementary and alternative medicine : eCAM2022

FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991.

Chao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.